916 Acquired resistance to immune checkpoint blockade by phenotypic plasticity of melanoma
Emily Robitschek(Broad Institute), Ryan J. Sullivan(Dana-Farber Cancer Institute), Genevieve M. Boland(Harvard University), Ivan Chebib(Massachusetts General Hospital), Keith T. Flaherty(Cancer Research Center), Tatyana Sharova(Harvard University), John H. Shin(Penn Center for AIDS Research), Alvin Shi(Broad Institute), Dennie T. Frederick(Broad Institute), Nir Hacohen(Cambridge Hospital), Jia‐Ren Lin(Harvard University), Rumya Raghavan(Broad Institute), Manolis Kellis(Broad Institute), David Liu(University of Louisville), Arnav Mehta(California Institute of Technology), Benchun Miao(Massachusetts General Hospital), Ana Larque(Hospital Clínic de Barcelona)
Cited by 1
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
|Nature|2009|4.2k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k